PRN: Interventional Cardiology Global Market - Expected to Grow at a High Single Digit CAGR to Reach $46,124.1 Million by 2023 - Research and Markets

06/mar/2017 15:02:44 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Interventional Cardiology Global Market - Expected to Grow at a High Single Digit CAGR to Reach $46,124.1 Million by 2023 - Research and Markets


DUBLIN, Mar 6, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Interventional Cardiology Global Market - Forecast to 2023" report to their offering.

The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023. Among the interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, coronary interventions is the largest segment and structural heart is the fastest growing segment with the strong CAGR.

Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.

Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Interventional Cardiology Global Market, by Product

5 Interventional Cardiology Global Market, by Application

6 Regional Analysis

7 Company Developments

8 Major Companies

Companies Mentioned:

  • Abbott Laboratories
  • Abiomed, Inc.
  • Acandis
  • Accellent Inc.
  • Acist Medical Systems
  • Admedes Schuessler Gmbh
  • Alpha Medical
  • Amg International Gmbh
  • Angiodynamics, Inc.
  • Angioslide, Inc.
  • APC Cardiovascular, Ltd.
  • Applied Medical
  • Argon Medical Devices
  • Arravasc, Ltd.
  • Articure Inc.
  • Asahi Intec
  • Ash Access Technology, Inc.
  • Asid Bonz Gmbh
  • Avinger, Inc.
  • B. Braun Melsungen AG
  • (100+ Others)

For more information about this report visit

Media Contact:

Research and Markets

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl